Menu

Entasis Therapeutics Holdings Inc. ETTX

Full chart Compare
Set alert

Price alert · ETTX

All alert types
2.19 +2.19

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $1.46MOther Operating Income → Expenses: $2.30MExpenses → Selling, General & Admin: $13.77MExpenses → Research & Development: $40.17MExpenses → Income Tax: $677.00KGross Profit → Expenses: $7.00MRevenue → Gross Profit: $7.00MNet Loss → Expenses: $43.85MOther Income$1.46MOther Operating Income$2.30MGross Profit$7.00MNet Loss$43.85MExpenses$54.61MSelling, General & Admin$13.77MResearch & Development$40.17MIncome Tax$677.00KRevenue$7.00M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

ETTX annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
52.32M54.23M53.94M43.21M31.34M
37.10M41.02M40.17M33.05M25.75M
15.21M13.21M13.77M10.16M5.60M
-52.32M-54.23M-46.94M-38.21M-31.34M
-47.14M-50.50M-43.85M-42.09M-29.92M
-47.14M-50.50M-43.85M-42.09M-29.92M
-47.14M-50.50M-43.85M-42.09M-29.92M
-47.14M-50.50M-43.85M-32.95M-29.92M
-1.09-2.10-3.33-12.31-13,795.76
-1.09-2.10-3.33-12.31-13,795.76
-1.09-2.10-3.33-12.31-13,795.76
-47.14M-50.50M-43.17M-41.62M-29.92M
-47.14M-50.50M-43.17M-41.62M-29.92M
43.34M24.06M13.16M3.42M2.17K
43.34M24.06M13.16M3.42M2.17K